Rosalind Advisors »

Journey Med Corp shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Journey Med Corp (DERM) shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Journey Med Corp

Tip: Access up to 7 years of quarterly data

All positions including Journey Med Corp held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Journey Med Corp by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $644k 114k 5.64

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Myomo Com New (MYO)
Mediwound Shs New (MDWD)
Optinose (OPTN)
Abeona Therapeutics- Com New (ABEO)
Xeris Pharmaceuticals (XERS)
Cellectar Biosciences Com New (CLRB)
Inspiremd (NSPR)
Cybin Ord (CYBN)
Ocular Therapeutix (OCUL)
Abivax Sa Sponsored Ads (ABVX)
Profound Medical Corp Com New (PROF)
Compass Pathways Sponsored Ads (CMPS)
Trevi Therapeutics (TRVI)
Kalvista Pharmaceuticals (KALV)

View all positions for Rosalind Advisors

Top funds holding Journey Med Corp

Vanguard Group
Cambridge Investment Research Advisors
Renaissance Technologies
American Financial Group
Pvg Asset Management
Tang Capital Management
Envestnet Asset Management
Rosalind Advisors
Geode Capital Management
Acadian Asset Management
Neuberger Berman Group
Geneos Wealth Management
Integrated Wealth Concepts
Atria Investments
BlackRock

View all funds holding Journey Med Corp